Equiver is a Mexican company with over 12 years of experience in the field of medical technology. Specializing in clinical diagnostic tests and molecular biology, Equiver's tests detect more than 100 viruses, bacteria, and fungi. Their scientific expertise has contributed to public health programs for over eight years, benefiting more than 15 million patients. With a strong track record, Equiver navigates the industry's challenges with intelligence and passion, positioning itself as a formidable competitor in the market. As a company that finances laboratories from conception to realization, Equiver is well-placed to thrive in the Mexican market in the Health Care industry. With no recent investment information available, Equiver presents an opportunity for potential investors seeking to contribute to the advancement of health technology in Mexico.
There is no investment information
No recent news or press coverage available for EQUIVER.